Natalizumab-induced pneumonitis.

Kaninia, Stefania; Edey, Anthony J; Maskell, Nick A; Rice, Claire M

Kaninia, Stefania; Edey, Anthony J; Maskell, Nick A; Rice, Claire M.

Kaninia S; Department of Neurology, North Bristol NHS Trust, Bristol, UK.
Edey AJ; Bristol Medical School, University of Bristol, Bristol, UK.
Maskell NA; Department of Radiology, North Bristol NHS Trust, Bristol, UK.
Rice CM; Bristol Medical School, University of Bristol, Bristol, UK.

J Neurol ; 269(3): 1688-1690, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-1709780

Subject(s)

Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Pneumonia; Humans; Immunologic Factors/adverse effects; Multiple Sclerosis/drug therapy; Natalizumab/adverse effects; Pneumonia/chemically induced; Pneumonia/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: English Journal: J Neurol Year: 2022 Document Type: Article Affiliation country: S00415-021-10811-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google